BACCEGA, TANIA
 Distribuzione geografica
Continente #
EU - Europa 165
NA - Nord America 152
AS - Asia 123
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 4
Totale 474
Nazione #
US - Stati Uniti d'America 145
RU - Federazione Russa 102
SG - Singapore 42
CN - Cina 38
HK - Hong Kong 16
IT - Italia 16
VN - Vietnam 12
BR - Brasile 10
DE - Germania 10
FR - Francia 8
SE - Svezia 8
GB - Regno Unito 6
CA - Canada 5
IN - India 5
ES - Italia 4
PL - Polonia 4
LT - Lituania 3
BD - Bangladesh 2
EC - Ecuador 2
IQ - Iraq 2
IR - Iran 2
JP - Giappone 2
MX - Messico 2
ZA - Sudafrica 2
AR - Argentina 1
AT - Austria 1
CL - Cile 1
ET - Etiopia 1
FI - Finlandia 1
GY - Guiana 1
HR - Croazia 1
ID - Indonesia 1
MY - Malesia 1
NL - Olanda 1
TN - Tunisia 1
Totale 459
Città #
Moscow 24
Singapore 23
Dallas 21
Hong Kong 15
Ashburn 13
San Jose 12
Beijing 11
New York 10
Council Bluffs 8
Perugia 8
Los Angeles 6
Munich 6
Hefei 5
Lauterbourg 5
Orem 5
Shanghai 5
Houston 4
Warsaw 4
Atlanta 3
Frankfurt am Main 3
Santa Clara 3
Baghdad 2
Boardman 2
Brooklyn 2
Chennai 2
Da Nang 2
Hanoi 2
Ho Chi Minh City 2
Johannesburg 2
Mexico City 2
Milan 2
Montreal 2
New Delhi 2
Seattle 2
Stockholm 2
São Paulo 2
The Dalles 2
Tokyo 2
Toronto 2
Washington 2
Addis Ababa 1
Bennettsville 1
Buffalo 1
Columbus 1
Duluth 1
Duque de Caxias 1
Eugene 1
Evansville 1
Fortaleza 1
Georgetown 1
Goya 1
Guangzhou 1
Guayaquil 1
Hacienda Ibarra 1
Hampton 1
Hangzhou 1
Helsinki 1
Hưng Yên 1
Hải Dương 1
Itatiba 1
Jakarta 1
Kirkcaldy 1
Kuala Lumpur 1
Lawrence 1
Louisville 1
Manassas 1
Manchester 1
Mount Prospect 1
Phoenix 1
Ponte Nova 1
Poplar 1
Porto Alegre 1
Princeton 1
Quincy 1
Quận Hai 1
Recife 1
Regina 1
Reston 1
Rio Grande 1
Riverside 1
Rome 1
Sousse 1
St Louis 1
Taquara 1
Tolentino 1
Tolleson 1
Vilnius 1
Winston-Salem 1
Wuhu 1
Zagreb 1
Totale 282
Nome #
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-/- iPSCs for β cell replacement 112
GENE SILENCING 105
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis 90
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC for cell therapy of type 1 diabetes 80
Engineering of NK activating receptor ligands enhances immune compatibility of MHC-I-/- iPSC-derived β cells for cell therapy of type 1 diabetes 78
Simultaneous orthogonal cell engineering by a single CRISPR-Cas9 polyfunctional editor 9
Totale 474
Categoria #
all - tutte 2.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.004


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 1 0 0 0 0 0 0 0 0
2022/202310 3 2 0 1 1 2 0 1 0 0 0 0
2023/202415 0 2 3 4 0 2 0 2 0 0 0 2
2024/202591 3 0 9 5 9 8 11 12 12 8 6 8
2025/2026334 20 18 24 47 25 20 26 30 90 19 10 5
2026/202722 6 16 0 0 0 0 0 0 0 0 0 0
Totale 474